Study of CRx-401 on Glucose Levels in Subjects With Type II Diabetes

Summary

This trial will assess the efficacy of CRx-401 in lowering FPG levels in patients taking metformin to treat their diabetes. In addition, this initial trial will evaluate insulin resistance (HOMA-IR index), HgbA1c levels, glycated protein, LDL, HDL, triglycerides, and total cholesterol, as well as the safety of CRx-401.

Timeline

Start

2007-07

Primary completion

2009-04

Completion

2009-05

Drugs

Indications